{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:58:31Z","timestamp":1787169511055,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate if addition of an anti-anaerobic agent to standard drug-cefazolin for antimicrobial prophylaxis would further decrease postoperative infectious morbidity or not. This is relevant as most of the infections in gynecological surgeries are anaerobic but cefazolin does not protect against anaerobes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The study design was a parallel randomized controlled trial. Two hundred patients undergoing benign gynecological surgeries were divided into two groups of 100 each. Group A received 2 g cefazolin 30\u201360 min before incision and Group B received 2 g cefazolin 30\u201360 min and 1.6 g tinidazole 60\u2013120 min before incision. The patients were followed for any infectious morbidity for 1 month postoperatively. The analysis was done separately for abdominal, laparoscopic, and vaginal surgeries. The analysis was also done for surgeries according to the wound category, i.e. clean and clean-contaminated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The two groups were comparable for age and body mass index (BMI). The two groups were comparable for the factors affecting infectious morbidity such as duration of surgery, blood loss, blood transfusions, duration of hospital stay, and need for additional antibiotics. The postoperative infectious morbidity was analyzed in terms of fever, surgical site infection (SSI), and urinary tract infection (UTI). No patient in vaginal and laparoscopic groups suffered from infectious morbidity. In abdominal surgeries group, postoperative fever occurred in 6\/74 (8.1%) and 11\/74 patients (14.8%) in Groups A and B, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.38). SSI occurred in 1\/74 (1.3%) and 2\/74 (2.7%) patients in Groups A and B, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 1.0). UTI occurred in 5\/74 patients (6.7%) and 2\/74 patients (2.7%) in Groups A and B, respectively (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.44). The data were also analyzed for infectious morbidity for clean and clean-contaminated wound categories, and the results were nonsignificant between both groups for each type of wound category (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Cefazolin alone is a sufficient antibiotic prophylaxis for benign gynecological procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/tcmj.tcmj_176_21","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T14:51:58Z","timestamp":1633099918000},"page":"207-213","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A randomized controlled trial to compare antibiotic prophylaxis in elective gynecological surgeries"],"prefix":"10.4103","volume":"34","author":[{"given":"Shivani","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Gainder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Bagga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Shafiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelam","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240828","doi-asserted-by":"crossref","first-page":"S879","DOI":"10.1093\/clinids\/13.Supplement_10.S879","article-title":"Cost and benefit of perioperative antimicrobial prophylaxis: Methods for economic analysis","volume":"13","author":"McGowan","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R2-12-20240828","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.0001-6349.2004.00609.x","article-title":"Postoperative infections and antibiotic prophylaxis for hysterectomy in Sweden: A study by the Swedish National Register for Gynecologic Surgery","volume":"83","author":"L\u00f6fgren","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R3-12-20240828","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinids\/13.5.803","article-title":"Mediastinitis complicating cardiac operations: Evidence of postoperative causation","volume":"13","author":"Ehrenkranz","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R4-12-20240828","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1586\/14787210.4.6.957","article-title":"Prophylactic antibiotics in obstetrics-gynecology: A current asset, a future liability?","volume":"4","author":"Ledger","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R5-12-20240828","first-page":"51","article-title":"Prophylactic antibiotics in elective major gynaecological surgery: Single perioperative dose vs multiple postoperative doses","volume":"37","author":"Dar","year":"1999","journal-title":"Mother Child"},{"key":"R6-12-20240828","first-page":"1068","article-title":"Usage of prophylactic antibiotics in uncomplicated gynecologic abdominal surgery in Siriraj Hospital","volume":"90","author":"Boriboonhirunsarn","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"R7-12-20240828","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/00016348609157361","article-title":"Single-dose intravenous tinidazole prophylaxis in abdominal hysterectomy","volume":"65","author":"Evaldson","year":"1986","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R8-12-20240828","doi-asserted-by":"crossref","first-page":"S650","DOI":"10.1093\/ofid\/ofx163.1732","article-title":"Should cefazolin be the first-line antimicrobial prophylaxis choice in patients undergoing hysterectomy.A systematic review and meta-analysis?","volume":"4","author":"Pop-Vicas","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"R9-12-20240828","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/(SICI)1098-0997(1999)7:3<169::AID-IDOG10>3.0.CO;2-J","article-title":"The role of bacterial vaginosis in infection after major gynecologic surgery","volume":"7","author":"Lin","year":"1999","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R10-12-20240828","first-page":"450","article-title":"Clue cells in predicting infections after abdominal hysterectomy","volume":"77","author":"Larsson","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R11-12-20240828","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000134783.98382.b0","article-title":"Vulvovaginal symptoms in women with bacterial vaginosis","volume":"104","author":"Klebanoff","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R12-12-20240828","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1155\/S1064744902000133","article-title":"Does pre- and postoperative metronidazole treatment lower vaginal cuff infection rate after abdominal hysterectomy among women with bacterial vaginosis?","volume":"10","author":"Larsson","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R13-12-20240828","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajog.2011.07.012","article-title":"Preoperative screening strategies for bacterial vaginosis prior to elective hysterectomy: A cost comparison study","volume":"205","author":"McElligott","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R14-12-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1590\/S0100-72032008001100003","article-title":"Tinidazole versus cefazolin in antibiotic prophylaxis of vaginal and abdominal hysterectomy","volume":"30","author":"Sim\u00f5es","year":"2008","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R15-12-20240828","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jac\/10.suppl_A.87","article-title":"Tinidazole in the prevention of post-operative wound infection after hysterectomy","volume":"10","author":"Janssens","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"R16-12-20240828","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/1471-0528.12178","article-title":"Antibiotic prophylaxis for hysterectomy, a prospective cohort study: Cefuroxime, metronidazole, or both?","volume":"120","author":"Brummer","year":"2013","journal-title":"BJOG"},{"key":"R17-12-20240828","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-9378(93)90266-L","article-title":"Avoiding serious infections associated with abdominal hysterectomy: A meta-analysis of antibiotic prophylaxis","volume":"169","author":"Mittendorf","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R18-12-20240828","first-page":"CD004637","article-title":"Antibiotic prophylaxis for elective hysterectomy","volume":"6","author":"Ayeleke","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_176_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:19Z","timestamp":1787166439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_176_21"}},"subtitle":["Single dose of cefazolin versus single dose of cefazolin and tinidazole"],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_176_21","relation":{},"ISSN":["1016-3190"],"issn-type":[{"value":"1016-3190","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}